A case of medication-related osteonecrosis of the jaw presumed to have been induced by Epstein-Barr virus-positive mucocutaneous ulcer in the maxillary gingiva

[1]  V. Hearnden,et al.  A Review Into the Effects of Pamidronic Acid and Zoledronic Acid on the Oral Mucosa in Medication-Related Osteonecrosis of the Jaw , 2022, Frontiers in Oral Health.

[2]  T. Nomura,et al.  Intraoral localized methotrexate‐associated lymphoproliferative disorders concurrent with antiresorptive agent‐related osteonecrosis of the jaw: A case report and literature review , 2020, Clinical case reports.

[3]  V. Hearnden,et al.  Synthetic Hydroxyapatite Inhibits Bisphosphonate Toxicity to the Oral Mucosa In Vitro , 2020, Materials.

[4]  M. Moriyama,et al.  Oral Methotrexate-related Lymphoproliferative Disease Presenting with Severe Osteonecrosis of the Jaw: A Case Report and Literature Review , 2017, Internal medicine.

[5]  A. Smith,et al.  Denosumab and osteonecrosis of the jaws - the pharmacology, pathogenesis and a report of two cases. , 2014, Australian dental journal.

[6]  S. Echigo,et al.  Two cases of alveolar osteonecrosis and tooth loss following trigeminal herpes zoster infection , 2013 .

[7]  I. Tohnai,et al.  A suspected case of both bisphosphonate-related osteonecrosis of the maxilla and methotrexate-associated lymphoproliferative disorder , 2012 .

[8]  P. Kostenuik,et al.  Bench to bedside: elucidation of the OPG–RANK–RANKL pathway and the development of denosumab , 2012, Nature Reviews Drug Discovery.

[9]  Y. Kitagawa,et al.  Nationwide survey for bisphosphonate-related osteonecrosis of the jaws in Japan. , 2011, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[10]  S. Cremers,et al.  Novel therapy to reverse the cellular effects of bisphosphonates on primary human oral fibroblasts. , 2011, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[11]  Y. Fujiwara,et al.  Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  H. Yatani,et al.  Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration, and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, without causing osteonecrosis of the jaw, in mice , 2010, Journal of Bone and Mineral Metabolism.

[13]  S. Cremers,et al.  Inhibition of oral mucosal cell wound healing by bisphosphonates. , 2008, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[14]  I. Reid,et al.  Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity? , 2007, Bone.

[15]  R. Marx.  Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. , 2003, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[16]  K. Kawa.  Diagnosis and treatment of epstein-barr virus-associated natural killer cell lymphoproliferative disease , 2003, International journal of hematology.

[17]  R. Coleman.  Skeletal complications of malignancy , 1997, Cancer.

[18]  T. Tursz,et al.  Epstein-Barr virus gene expression in nasopharyngeal carcinoma. , 1988, The Journal of general virology.

[19]  M. Epstein,et al.  VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA. , 1964, Lancet.

[20]  H. Hiratsuka,et al.  A case of methotrexate-associated lymphoproliferative disorders simultaneously arising in the maxilla and the nasal mucosa of a patient receiving bisphosphonate , 2017 .

[21]  T. Komori,et al.  A case of methotrexate-associated lymphoproliferative disorders arising in the gingiva of the maxilla and mandible , 2013 .

[22]  Y. Minami,et al.  A case of rheumatoid arthritis associated with bisphosphonate-related osteonecrosis of the jaw and methotrexate-associated lymphoproliferative disorde , 2012 .